Cyclobarbital

From WikiMD's Medical Encyclopedia

Cyclobarbital, also known as cyclobarbitone in some regions, is a barbiturate derivative used primarily as a sedative and hypnotic. It was first synthesized in the early 20th century and has been utilized in the treatment of insomnia and as a component in some anesthetic protocols. Like other barbiturates, cyclobarbital acts by enhancing the action of GABA (gamma-aminobutyric acid), a neurotransmitter that inhibits the activity of neurons, leading to sedation and hypnosis.

Chemical Properties[edit]

Cyclobarbital is chemically known as 5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid. It is a white, crystalline substance that is soluble in alcohol and ether but relatively insoluble in water. Its molecular formula is C12H16N2O3.

Pharmacology[edit]

The pharmacological action of cyclobarbital involves the potentiation of GABAergic neurotransmission, which in turn leads to the depression of the central nervous system (CNS). This results in sedative, hypnotic, and anticonvulsant effects. Cyclobarbital's onset of action is relatively rapid, and its effects can last for several hours, making it effective for the induction of sleep and maintenance of sedation.

Clinical Uses[edit]

Cyclobarbital has been used for the treatment of insomnia and as a pre-anesthetic medication to induce sedation before surgical procedures. However, its use has declined over the years due to the development of newer drugs with fewer side effects and lower risk of dependence.

Side Effects and Risks[edit]

The use of cyclobarbital, like other barbiturates, is associated with a range of side effects including drowsiness, dizziness, and impaired coordination. Long-term use or abuse can lead to dependence and withdrawal symptoms upon cessation. Overdose can result in severe respiratory depression, coma, and death. Due to these risks, cyclobarbital is now less commonly prescribed, with preference given to benzodiazepines and other non-barbiturate sedatives.

Regulation and Control[edit]

Cyclobarbital is classified as a controlled substance in many countries, subject to regulations that govern its prescription and distribution. Its potential for abuse and dependence has led to strict controls to minimize misuse.

Conclusion[edit]

While cyclobarbital played an important role in the management of insomnia and as a sedative in the past, its use today is limited due to the availability of safer alternatives. Its history in medicine, however, provides valuable insights into the development of sedative-hypnotic drugs and the evolution of pharmacotherapy in sleep disorders.

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.